Page last updated: 2024-08-23

diaziquone and Bone Marrow Diseases

diaziquone has been researched along with Bone Marrow Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bedikian, AY; Benjamin, RS; Burgess, MA; Feun, LG; Fields, WS; Leavens, ME; Obbens, EA; Savaraj, N; Stewart, DJ; Yung, WK1
Bruntsch, U; Cavalli, F; Høst, H; Joss, R; Pinedo, H; Renard, G; Rozencweig, M; van Glabbeke, M1
Ettinger, LJ; Hammond, GD; Krailo, MD; Krivit, WA; Ru, N; Ruccione, KS1
Dicke, KA; Spitzer, G1
Ettinger, LJ; Hammond, GD; Krailo, M; Krivit, W; Ruccione, KS1
Bukowski, R; Crawford, ED; Kirby, R; O'Bryan, RM; Rivkin, SE; Stephens, RL1

Reviews

1 review(s) available for diaziquone and Bone Marrow Diseases

ArticleYear
Evaluation of the use of high-dose cytoreduction with autologous marrow rescue in various malignancies.
    Transplantation, 1986, Volume: 41, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Bone Marrow Diseases; Bone Marrow Transplantation; Breast Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Evaluation; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasms; Neuroblastoma; Transplantation, Autologous

1986

Trials

1 trial(s) available for diaziquone and Bone Marrow Diseases

ArticleYear
A phase II study of diaziquone in children with recurrent or progressive solid tumors. Report from the Childrens Cancer Study Group.
    The American journal of pediatric hematology/oncology, 1990,Fall, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Bone Marrow Diseases; Child; Child, Preschool; Drug Evaluation; Humans; Infant; Lymphoma; Neoplasm Recurrence, Local; Neoplasms

1990

Other Studies

4 other study(ies) available for diaziquone and Bone Marrow Diseases

ArticleYear
A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors.
    Journal of neuro-oncology, 1984, Volume: 2, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Astrocytoma; Aziridines; Azirines; Benzoquinones; Bone Marrow Diseases; Brain Neoplasms; Drug Evaluation; Glioblastoma; Glioma; Humans; Middle Aged; Neoplasm Recurrence, Local

1984
Phase II trial of diaziquone (AZQ) in advanced malignant melanoma.
    European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Blood Cell Count; Bone Marrow Diseases; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Soft Tissue Neoplasms

1983
A phase II study of diaziquone in childhood leukemia: a report from the Children's Cancer Study Group.
    The American journal of pediatric hematology/oncology, 1988,Spring, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Bone Marrow Diseases; Brain Neoplasms; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Leukemia; Male

1988
High dose AZQ in renal cancer. A Southwest Oncology Group phase II study.
    Investigational new drugs, 1986, Volume: 4, Issue:1

    Topics: Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Bone Marrow Diseases; Carcinoma, Renal Cell; Drug Evaluation; Humans; Kidney Neoplasms; Leukocyte Count; Platelet Count

1986